FreeIn the Archives Waun Ki Hong, legend and “mentor magnificus,” in his own words May 24, 2024Vol.50 No.21
HRD results can vary widely, depending on what assay you choose—even as they guide treatment choices May 17, 2024Vol.50 No.20By Jacquelyn Cobb
Conversation with The Cancer Letter NCI’s Lisa McShane: We need to understand the implications of HRD assay discordance May 17, 2024Vol.50 No.20By Jacquelyn Cobb
RWE study pinpoints gaps in mental health care utilization among parents of children with cancer May 17, 2024Vol.50 No.20By McKenzie Prillaman
Capitol Hill Sen. Durbin weighs in on the controversy about dosage of Amgen drug sotorasib May 17, 2024Vol.50 No.20By Paul Goldberg
Guest Editorial Regulators must step in to safeguard patient data in the AI era May 17, 2024Vol.50 No.20By Mika Newton
Cancer History ProjectConversation with The Cancer LetterFree 2024 Karnofsky Award winner Lillian Siu talks about her career in phase I studies, ctDNA, and her mentor’s “evil red pencil” May 10, 2024Vol.50 No.19By Jacquelyn Cobb
Trials & Tribulations Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity May 10, 2024Vol.50 No.19By Sanju Sinha and Eytan Ruppin
Guest Editorial OCE’s Project 5 in 5 seeks to inspire pragmatic innovation May 10, 2024Vol.50 No.19By Steven C. Cunningham, Donna R. Rivera, Richard Pazdur, Kelly J. Norsworthy and Jennifer Gao
Guest Editorial Voices of Black women can improve cancer outcomes May 10, 2024Vol.50 No.19By Alpa V. Patel
